A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancer von Ko, A H, Tempero, M A, Shan, Y-S, Su, W-C, Lin, Y-L, Dito, E, Ong, A, Wang, Y-W, Yeh, C G, Chen, L-T

Volltext

Pancreatic cancer treatment and research: an international expert panel discussion von Tempero, M.A., Berlin, J., Ducreux, M., Haller, D., Harper, P., Khayat, D., Schmoll, H.-J., Sobrero, A., Van Cutsem, E.

Volltext

A phase 1 trial of imatinib, bevacizumab, and metronomic cyclophosphamide in advanced colorectal cancer von Kelley, R K, Hwang, J, Magbanua, M J M, Watt, L, Beumer, J H, Christner, S M, Baruchel, S, Wu, B, Fong, L, Yeh, B M, Moore, A P, Ko, A H, Korn, W M, Rajpal, S, Park, J W, Tempero, M A, Venook, A P, Bergsland, E K

Volltext

Serum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer von Ko, A H, Hwang, J, Venook, A P, Abbruzzese, J L, Bergsland, E K, Tempero, M A

Volltext

Health-related quality of life (HRQoL) in patients with early-stage pancreatic cancer (ESPC) receiving adjuvant or neoadjuvant chemotherapy (A/NAC): A systematic literature review... von Macarulla Mercade, T., Hendifar, A., Li, C.-P., Reni, M., Riess, H., Tempero, M.A., Dueck, A., Botteman, M.F., Deshpande, C., Lucas, E., Oh, D.-Y.

Volltext

HALO 109-301: Phase III, randomized, double-blind, placebo-controlled study of pegvorhyaluronidase alfa (PEGPH20) + nab-paclitaxel/gemcitabine (AG) in patients with previously untr... von Van Cutsem, E., Corrie, P.G., Ducreux, M.P., Sigal, D., Sahai, V., Oh, D.-Y., Bullock, A., Bang, Y.-J., Baron, A.D., Hendifar, A., Li, C.-P., Philip, P., Reni, M., Zalupski, M., Zheng, L., Berman, C., Chondros, D., Tempero, M.A.

Volltext

AGA technical review on the epidemiology, diagnosis, and treatment of pancreatic ductal adenocarcinoma von DiMagno, Eugene P., Reber, Howard A., Tempero, Margaret A.

Volltext

Outpatient treatment with (131)I-anti-B1 antibody: radiation exposure to family members von Rutar, F J, Augustine, S C, Colcher, D, Siegel, J A, Jacobson, D A, Tempero, M A, Dukat, V J, Hohenstein, M A, Gobar, L S, Vose, J M

Volltext

Fatal pulmonary toxicity resulting from treatment with gemcitabine von Tempero, Margaret A., Brand, Randall

Volltext

Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer von TEMPERO, M. A, UCHIDA, E, TAKASAKI, H, BURNETT, D. A, STEPLEWSKI, Z, POUR, P. M

Volltext

Association of age with survival in patients with metastatic colorectal cancer: analysis from the ARCAD Clinical Trials Program von Lieu, Christopher H, Renfro, Lindsay A, de Gramont, Aimery, Meyers, Jeffrey P, Maughan, Timothy S, Seymour, Matthew T, Saltz, Leonard, Goldberg, Richard M, Sargent, Daniel J, Eckhardt, S Gail, Eng, Cathy

Volltext

New frontiers in the therapeutic landscape for metastatic pancreatic cancer von Tempero, M.A.

Volltext

A white paper : The product of a pancreas cancer think tank von KERN, Scott, HRUBAN, Ralph, HOLLINGSWORTH, Michael A, BRAND, Randall, ADRIAN, Thomas E, JAFFEE, Elizabeth, TEMPERO, Margaret A

Volltext

Patient-Specific Dosimetry of Indium-111- and Yttrium-90-Labeled Monoclonal Antibody CC49 von Leichner, Peter K, Akabani, Gamal, Colcher, David, Harrison, Katherine A, Hawkins, William G, Eckblade, Miriam, Baranowska-Kortylewicz, Janina, Augustine, Samuel C, Wisecarver, James, Tempero, Margaret A

Volltext

The effect of garlic extract on human metabolism of acetaminophen von Gwilt, P R, Lear, C L, Tempero, M A, Birt, D D, Grandjean, A C, Ruddon, R W, Nagel, D L

Volltext

741PHealth-related quality of life (HRQoL) in patients with early-stage pancreatic cancer (ESPC) receiving adjuvant or neoadjuvant chemotherapy (A/NAC): A systematic literature rev... von Macarulla Mercade, T, Hendifar, A, Li, C-P, Reni, M, Riess, H, Tempero, M A, Dueck, A, Botteman, M F, Deshpande, C, Lucas, E, Oh, D-Y

Volltext

684PImpact of adjuvant treatment with nab-paclitaxel and gemcitabine (nab-P+GEM) vs gemcitabine alone (GEM) on health-related quality of life (QoL) in patients (pts) with surgicall... von Riess, H, Braverman, J, Reni, M, Dueck, A C, Hendifar, A, Oh, D-Y, Li, C-P, Mercade, T Macarulla, Shah, A, Joshi, N, Botterman, M, Mantovani, E, Lu, B, Tempero, M A

Volltext

687PEvaluation of minimal important difference (MID) for the European organisation for research and treatment of cancer (EORTC) pancreatic cancer module (PAN26) in patients with su... von Reni, M, Braverman, J, Hendifar, A, Li, C-P, Macarulla Mercade, T, Oh, D-Y, Riess, H, Tempero, M A, Lu, B, Marcus, J, Joshi, N, Botterman, M, Dueck, A C

Volltext

682PPhase III, international, multicenter, randomized, open-label trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) alone for surgically resected pancr... von Tempero, M A, Reni, M, Riess, H, O’Reilly, E M, Krishnamurthi, S, Österlund, P, Ales-Diaz, I C, Milella, M, Siena, S, Tabernero, J, Van Cutsem, E, Philip, P A, Goldstein, D, Berlin, J D, Li, M, Ferrara, S, Bruchec, Y Le, McGovern, D, Biankin, A

Volltext

789TiPHALO 109-301: Phase III, randomized, double-blind, placebo-controlled study of pegvorhyaluronidase alfa (PEGPH20) + nab-paclitaxel/gemcitabine (AG) in patients with previousl... von Van Cutsem, E, Corrie, P G, Ducreux, M P, Sigal, D, Sahai, V, Oh, D-Y, Bullock, A, Bang, Y-J, Baron, A D, Hendifar, A, Li, C-P, Philip, P, Reni, M, Zalupski, M, Zheng, L, Berman, C, Chondros, D, Tempero, M A

Volltext